vTv Therapeutics LLC (vTv) is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. Our mission is to advance clinical drug candidates discovered with our innovative technology into safe and effective medicines.
vTv has a powerful pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including Alzheimer’s disease, diabetes and inflammation. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality and breadth of vTv’s product candidate pipeline, platform technology, scientific team and strategic collaborations have enabled it to become a leader in its novel therapeutic targets.